Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
|Articles|February 27, 2018
- February 2018 Immunization Supplement
- Volume 84
- Issue 2
Guide to Adult Immunizations
Advertisement
View the PDF
References
1. American Academy of Pediatrics. Recommended Childhood and Adolescent Immunizaiton Schedules: United States, 2018. http://pediatrics.aappublications.org/content/early/2018/02/02/ peds.2018-0083. Accessed February 6, 2018.
2. Centers for Disease Control and Prevention. www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html#changes. Accessed February 6, 2018.
Articles in this issue
over 8 years ago
Herpes Zoster: Talking Points on the New Vaccine for Patientsover 8 years ago
Improving Adherence With Immunization SchedulesAdvertisement
Related to this article
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Getting patients vaccinated matters more than which COVID-19 vaccine they receive, says Jodi Longueil, PharmD.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
2
Asundexian Receives FDA Approval, Becomes First FXIa Inhibitor for Secondary Stroke Risk Reduction
3
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
4
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
5